Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.17 $1.66 Friday, 10th May 2024 IFRX stock ended at $1.18. This is 1.67% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 6.41% from a day low at $1.17 to a day high of $1.25.
90 days $1.17 $1.92
52 weeks $1.14 $5.20

Historical InflaRx N.V. prices

Date Open High Low Close Volume
Apr 05, 2024 $1.56 $1.68 $1.50 $1.55 364 003
Apr 04, 2024 $1.55 $1.59 $1.50 $1.56 140 064
Apr 03, 2024 $1.54 $1.66 $1.52 $1.55 221 929
Apr 02, 2024 $1.55 $1.58 $1.51 $1.54 56 311
Apr 01, 2024 $1.55 $1.59 $1.51 $1.52 49 940
Mar 28, 2024 $1.57 $1.57 $1.51 $1.54 316 758
Mar 27, 2024 $1.52 $1.60 $1.52 $1.54 189 797
Mar 26, 2024 $1.54 $1.60 $1.52 $1.54 95 935
Mar 25, 2024 $1.50 $1.61 $1.50 $1.54 146 843
Mar 22, 2024 $1.53 $1.59 $1.49 $1.49 396 480
Mar 21, 2024 $1.43 $1.70 $1.40 $1.54 624 635
Mar 20, 2024 $1.69 $1.75 $1.64 $1.69 239 435
Mar 19, 2024 $1.58 $1.82 $1.54 $1.69 254 019
Mar 18, 2024 $1.55 $1.57 $1.50 $1.50 149 022
Mar 15, 2024 $1.50 $1.62 $1.49 $1.58 123 709
Mar 14, 2024 $1.56 $1.57 $1.48 $1.52 91 783
Mar 13, 2024 $1.56 $1.62 $1.56 $1.58 67 055
Mar 12, 2024 $1.65 $1.69 $1.56 $1.57 120 543
Mar 11, 2024 $1.61 $1.71 $1.58 $1.62 170 802
Mar 08, 2024 $1.66 $1.74 $1.62 $1.62 45 280
Mar 07, 2024 $1.71 $1.76 $1.64 $1.66 142 724
Mar 06, 2024 $1.75 $1.84 $1.72 $1.74 191 291
Mar 05, 2024 $1.73 $1.82 $1.72 $1.79 98 340
Mar 04, 2024 $1.71 $1.89 $1.67 $1.77 341 127
Mar 01, 2024 $1.80 $1.88 $1.70 $1.75 366 973
Click to get the best stock tips daily for free!

About InflaRx N.V.

InflaRx N.V. InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III c... IFRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT